BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19743504)

  • 1. Degradation of paclitaxel and related compounds in aqueous solutions III: Degradation under acidic pH conditions and overall kinetics.
    Tian J; Stella VJ
    J Pharm Sci; 2010 Mar; 99(3):1288-98. PubMed ID: 19743504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of paclitaxel and related compounds in aqueous solutions II: Nonepimerization degradation under neutral to basic pH conditions.
    Tian J; Stella VJ
    J Pharm Sci; 2008 Aug; 97(8):3100-8. PubMed ID: 17963215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of paclitaxel and related compounds in aqueous solutions I: epimerization.
    Tian J; Stella VJ
    J Pharm Sci; 2008 Mar; 97(3):1224-35. PubMed ID: 17680660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The taxol pathway 10-O-acetyltransferase shows regioselective promiscuity with the oxetane hydroxyl of 4-deacetyltaxanes.
    Ondari ME; Walker KD
    J Am Chem Soc; 2008 Dec; 130(50):17187-94. PubMed ID: 19007225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and degradation profiles of Spantide II in aqueous solutions.
    Kikwai L; Babu RJ; Kanikkannan N; Singh M
    Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of ricobendazole in aqueous solutions.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocatalysis of precursors to new-generation SB-T-taxanes effective against paclitaxel-resistant cancer cells.
    Al-Hilfi A; Walker KD
    Arch Biochem Biophys; 2022 Apr; 719():109165. PubMed ID: 35227656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
    Roskar R; Simoncic Z; Gartner A; Kmetec V
    J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ultrasonic processing on degradation of salvianolic acid B in aqueous solution.
    Guo YX; Zhang L; Lu L; Liu EH; Shi CZ
    J Pharm Biomed Anal; 2016 Sep; 129():252-259. PubMed ID: 27442887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and mechanism of degradation of lithospermic acid B in aqueous solution.
    Guo YX; Xiu ZL; Zhang DJ; Wang H; Wang LX; Xiao HB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1249-55. PubMed ID: 17118607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioproduction of baccatin III, an advanced precursor of paclitaxol, with transgenic Flammulina velutipes expressing the 10-deacetylbaccatin III-10-O-acetyl transferase gene.
    Han F; Kang LZ; Zeng XL; Ye ZW; Guo LQ; Lin JF
    J Sci Food Agric; 2014 Sep; 94(12):2376-83. PubMed ID: 24403190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation kinetics of methacrylated dextrans in aqueous solution.
    van Dijk-Wolthuis WN; van Steenbergen MJ; Underberg WJ; Hennink WE
    J Pharm Sci; 1997 Apr; 86(4):413-7. PubMed ID: 9109041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of the acid-catalyzed hydrolysis of acyclovir and an ester prodrug in aqueous solution.
    Jensen E; Bundgaard H
    Acta Pharm Nord; 1991; 3(3):147-50. PubMed ID: 1793509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards validating new enzymatic routes for synthetic conversion: 7,10-bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetyl baccatin III-ethyl acetate-water (1/1/1).
    Wang L; Li YJ; Li ZW
    Acta Crystallogr C Struct Chem; 2015 Mar; 71(Pt 3):191-4. PubMed ID: 25734848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Deacetylbaccatin III: a proposed biosynthetic precursor of paclitaxel from the bark of Taxus wallichiana.
    Nisar M; Qayum M; Adhikari A; Khan I; Kaleem WA; Ali Z; Choudhary MI
    Nat Prod Commun; 2010 Nov; 5(11):1727-8. PubMed ID: 21213967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of BMS-753493, a novel epothilone folate conjugate anticancer agent.
    Gokhale M; Thakur A; Rinaldi F
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1315-27. PubMed ID: 23039020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tour de paclitaxel: biocatalysis for semisynthesis.
    Patel RN
    Annu Rev Microbiol; 1998; 52():361-95. PubMed ID: 9891802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
    Xiang TX; Niemi R; Bummer P; Anderson BD
    J Pharm Sci; 2003 Oct; 92(10):2027-39. PubMed ID: 14502542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal changes in the concentrations of four taxoids in Taxus baccata L. during the autumn-spring period.
    Glowniak K; Mroczek T; Zobel AM
    Phytomedicine; 1999 May; 6(2):135-40. PubMed ID: 10374254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.